MPM BioImpact’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.06M Sell
2025
Q1
$964K Sell
2024
Q4
$2.75M Hold
2024
Q3
$4.84M Hold
2024
Q2
$4.97M Hold
2024
Q1
$8.05M Hold
2023
Q4
$4.04M Hold
2023
Q3
$3.97M Hold
2023
Q2
$4.71M Buy